Whole population BRCA screening is cost effective in Israel, even with varying prevalence of BRCA mutation
Michaan, N., Lashno, M., Safra, T., Merose, R., Laskov, I., Grisaru, D.Volume:
154
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.520
Date:
June, 2019
File:
PDF, 375 KB
english, 2019